Anti-Therapeutic Action: cardiotoxicity

The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology

Researchers are rediscovering psychedelic compounds from traditional plants and fungi as potential treatments for mental health conditions and addiction. These substances work by interacting with brain chemistry, particularly serotonin systems, to reduce symptoms of depression, anxiety, and drug cravings. Recent clinical studies show promising results, especially for treating opioid addiction with single doses that can produce lasting improvements. However, more rigorous clinical trials are needed to fully understand how these compounds work and to establish safe, effective therapeutic protocols.

Read More »

The Role of Psychedelics in the Treatment of Substance Use Disorders: An Overview of Systematic Reviews

This research review examines how psychedelic drugs like psilocybin and ketamine might help treat addiction. Studies show these substances could help people quit alcohol, drugs, and smoking by reducing cravings and promoting long-term abstinence. While results are promising, scientists caution that more rigorous research is needed before these treatments can be recommended for regular medical use, and they acknowledge real risks associated with these powerful drugs.

Read More »

Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans

This comprehensive review examines how scientists use advanced imaging techniques like PET and SPECT scans to study how hallucinogenic drugs such as LSD and psilocybin interact with the brain. The research shows these drugs primarily bind to serotonin receptors, particularly the 5-HT2A subtype, which appear responsible for producing hallucinations. While scientific understanding of hallucinogen mechanisms has advanced significantly, there is still much to learn about their complete effects on brain chemistry and their potential therapeutic applications.

Read More »

Local mushroom poisoning: a case report study

A 26-year-old woman became severely ill after eating poisonous mountain mushrooms she mistakenly thought were edible. She developed serious heart problems, elevated liver enzymes, and inflammation of the pancreas, requiring intensive care and a heart defibrillator shock. After receiving NAC (N-acetylcysteine) infusions and dialysis for a week, she gradually recovered and was eventually discharged in good condition. This case highlights the dangers of wild mushroom foraging and the importance of seeking immediate medical attention if poisoning is suspected.

Read More »
Scroll to Top